zofran lawyer

  • Date: Apr 23, 2015
  • Category: Family

The First Lawsuit Alleging Zofran Caused Cleft Palate

On April 3, 2015, parents from Billings, Montana became America’s first family to file a lawsuit claiming that GlaxoSmithKline’s anti-nausea drug Zofran caused their child’s cleft palate. In 2012, researchers from Harvard University found that women prescribed Zofran’s active ingredient were twice as likely to deliver babies with cleft palate. Led by Monheit Law, a multistate alliance of attorneys has joined forces to investigate similar claims against Zofran’s manufacturer. Continue reading →

  • Date: Apr 13, 2015
  • Category: Legal

Zofran Lawsuits Seek Damages For Twelve Birth Defects

GlaxoSmithKline’s Zofran, which is FDA approved to treat severe nausea and vomiting only in cancer patients and those undergoing surgical anesthesia, has also become a leading treatment for morning sickness, despite the fact that its effects during pregnancy have never been adequately studied. Four lawsuits have now been filed, claiming that Zofran has the potential to cause birth defects and that GlaxoSmithKline was aware of the drug’s potential dangers but marketed it to pregnant women’s physicians anyway. In total, plaintiffs allege that GlaxoSmithKline’s medication caused twelve separate birth defects. Continue reading →

  • Date: Apr 08, 2015
  • Category: Family

Four Lawsuits Claim That Child Birth Defects Were Caused By Zofran

Four families have now filed lawsuits against GlaxoSmithKline, alleging that the pharmaceutical giant’s anti-nausea drug Zofran caused their children’s debilitating birth defects. While Zofran is FDA approved to treat nausea and vomiting in patients undergoing cancer treatments and surgical anesthesia, it has never been approved for morning sickness. In their complaints, plaintiffs claim that GlaxoSmithKline not only failed to test Zofran’s effects on fetal development, but may in fact have known of the drug’s significant health risks and failed to warn the public. Continue reading →

  • Date: Mar 23, 2015
  • Category: Family

Multiple Research Studies Establish Possible Link Between Zofran & Birth Defects

Multiple epidemiological studies have begun to establish an association between the drug ondansetron, marketed by GlaxoSmithKline as Zofran, and severe birth defects. Joined by an alliance of distinguished plaintiffs’ attorneys, Monheit Law discusses this most recent research, along with allegations in filed lawsuits (Eastern District of Pennsylvania case number 2:15-cv-00709PD and District of Massachusetts case number 1:15-cv-10429) that GlaxoSmithKline was aware of these dangers but did nothing to warn the health community or public. Continue reading →

  • Date: Mar 23, 2015
  • Category: Family

Multiple Research Studies Establish Possible Link Between Zofran & Birth Defects

Multiple epidemiological studies have begun to establish an association between the drug ondansetron, marketed by GlaxoSmithKline as Zofran, and severe birth defects. Joined by an alliance of distinguished plaintiffs’ attorneys, Monheit Law discusses this most recent research, along with allegations in filed lawsuits (Eastern District of Pennsylvania case number 2:15-cv-00709PD and District of Massachusetts case number 1:15-cv-10429) that GlaxoSmithKline was aware of these dangers but did nothing to warn the health community or public. Continue reading →

  • Date: Mar 17, 2015
  • Category: Legal

Monheit Law Releases A 12 Point Guide To Zofran Birth Defect Lawsuits

In order to better inform the public, a national coalition of distinguished plaintiffs’ attorneys has released a comprehensive guide on litigation surrounding GlaxoSmithKline’s popular anti-nausea drug Zofran. Recent studies have begun to establish a link between Zofran’s active ingredient, Ondansetron, and severe birth defects including cleft palate and congenital heart defects. Now, recently-filed lawsuits (filed under case numbers 1:15-cv-10429 and 2:15-cv-00709PD) claim that GlaxoSmithKline was aware of Zofran’s risks, but unlawfully marketed the drug to obstetricians and gynecologists as a safe treatment for morning sickness. Continue reading →

National Alliance of Attorneys Filing Zofran Birth Defect Lawsuits

A national alliance of plaintiffs’ attorneys have begun filing Zofran birth defect lawsuits. Several independent studies have linked Zofran to a potential increased risk of child birth defects such as cleft palate, and congenital heart defects. Continue reading →